Abstract
Antimicrobial resistance (AMR) causes over 1.27 million deaths annually and was worsened by the COVID-19 pandemic, emphasising the need for robust antimicrobial stewardship (AMS). This poster evaluates a structured Public and Patient Involvement (PPI) approach embedded within a three-phase NHS AMS research programme. PPI informed study design, implementation, and communication across systematic review, retrospective analysis, and survey components. The East of England Citizens’ Senate reviewed study materials, enhancing survey clarity and engagement. PPI tools such as patient-informed videos and accessible visuals improved participation and dissemination, achieving measurable gains in communication impact and inclusivity.
| Original language | English |
|---|---|
| Pages | 1 |
| Number of pages | 1 |
| Publication status | Published - 7 Nov 2025 |
| Event | Royal Pharmaceutical Society Conference 2025 - London, United Kingdom Duration: 7 Nov 2025 → 7 Nov 2025 |
Conference
| Conference | Royal Pharmaceutical Society Conference 2025 |
|---|---|
| Country/Territory | United Kingdom |
| City | London |
| Period | 7/11/25 → 7/11/25 |
Keywords
- antimicrobial resistance
- Antimicrobial Resistance
- Antimicrobial resistance (AMR)
- Antimicrobial Resistance (AMR)
- Antimicrobial resistance,
- Antimicrobial stewardship
- Antimicrobial Stewardship
- antimicrobial stewardship (AMS)
- antimicrobial stewardship (ASP) intervention
- antimicrobial stewardship outcome
- Antimicrobial stewardship programme
- Antimicrobial stewardship programs
- Public and Patient Involvement
- Public and patient
- public involvement
- Public Involvement
- Public involvement in research
- Public involvement lead
- Covid-19
- COVID-19 pandemic
- NHS research
- Co-production
- health communication
- public engagement
- Public engagement
- public health
- Public health
- PUBLIC HEALTH
- Public health concern
- Public Health England